Afrigen, Univercells partner to develop African-owned Covid-19 vaccine


Share post:

Afrigen Biologics has signed an agreement with the Univercells Group to develop the first African-owned Covid-19 vaccine. 

The partnership will focus on developing a new messenger ribonucleic acid (mRNA) vaccine leveraging intellectual property (IP) from both parties, as well as a new IP and boosting access to the shot. 

mRNA specialist eTheRNA will extend support to Afrigen and Univercells in the partnership.

The firms will jointly work to address two key challenges, the lack of domestic cost-efficient manufacturing and the requirement for cold- or super-cold chains.

These two have obstructed the rollout of Covid-19 vaccines in Africa and other low- and middle-income countries (LMICs).

Currently, African nations import 99% of the vaccines that they use.

In addition, cold chain storage and supply, particularly the super-cold chains needed for current mRNA vaccines are costly and are logistically challenging for various countries. 

Under the deal, an mRNA vaccine that is thermostable at refrigerator temperatures will be produced, making it easier for storage and supply in rural and remote areas where vaccination rates are still low.

The new alliance will be hosted by Afrigen at its sites in Cape Town, South Africa. 

Afrigen hosts the Global mRNA Vaccine Technology Transfer Hub of World Health Organization and is working to aid in mRNA vaccines production at more than 15 designated manufacturing sites in LMICs globally. 

The latest development comes a year after the establishment of the mRNA Vaccine Technology Transfer Hub.

The alliance and the potential vaccine will be based on the capabilities developed through the hub.

Apart from developing a new vaccine, the partnership intends to develop a new manufacturing model for mRNA vaccines. 

Afrigen managing director professor Petro Terblanche said: “The Covid-19 pandemic has shown that there is a pressing need to build African capabilities in vaccine development and manufacturing. 

“Without the capacity to make their own vaccines, too many countries haven’t been able to access them. 

“This agreement is an important step towards ensuring that everyone, everywhere – in Africa, and across LMICs – has access to life-saving vaccines and medicines.”

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Free Whitepaper


Secure the cell therapy supply chain from bench to bedside

The development of cell therapies is changing healthcare, delivering new hope to thousands of patients around the world. The vein-to-vein workflow for these therapies, however, is not without challenges, many of which will increase as we scale up to treat more patients. Download this free guide from Cytiva to learn more about the challenges and risks associated with the cryogenic supply chain for cell therapies, and how supply chain disruptions can best be mitigated.

by Cytiva Thematic

By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy
By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.


Please enter your comment!
Please enter your name here


Related articles

America’s pastime thrills us again | News, Sports, Jobs

<!-- SHOW ARTICLE --> Some contend baseball is the great American pastime. I wouldn’t argue — especially...

Being Latino In The U.S.: A Conversation With Prof. Coury

In August 1988, Congress wrote Hispanic Heritage Month into law starting every year on Sept. 15 and...

Cooper Rush and the greatest UDFA quarterbacks since 2000

Wins and losses are not quarterback stats. Fortunately, that was the only bit of bad luck Tony...

Mass fish deaths in European river blamed on toxic algae

<!-- Mass fish deaths in European river blamed on toxic algae | News Room Odisha ...
English English Somali Somali